Acura Pharmaceuticals Inc (ACUR)

0.43 +0.08  +22.86% OTC Markets Jan 17, 20:00 Delayed 15m USD
View Full Chart
Price Chart
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: Illinois
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Nov. 15, 2017
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Acura Pharmaceuticals Inc is a specialty pharmaceutical company based in the United States. It is engaged in the research, development, and commercialization of technologies and products intended to address medication abuse and misuse. The company has developed Aversion and Limitx technologies are intended to address methods of abuse associated with opioid analgesics whereas Impede technology is directed at minimizing the extraction and conversion of pseudoephedrine (PSE), into methamphetamine. Its product line includes OXAYDO which is a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and other pipeline products.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.